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Abstract 
Performance of BACTEC 9120 blood culture system was compared with the conventional (manual) 
broth method in detecting blood cultures of 500 patients suffering from various diseases. The BACTEC 
system proved to be superior in both yield and speed of detection. Four species of yeasts belonging to 2 
genera  and  13  species of  bacteria  belonging to 12  genera were  recovered  from  the patient's  blood 
cultures. The study confirmed the serious role of yeasts  present  in  patient  blood, and  highlighted the 
serious  pathological  effect of their  secondary  metabolites,  including clinical symptoms  ending with 
death, besides the changes in the histological  pattern in the internal organs, as liver, kidney and spleen 
using mice as an experimental animal model. 
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1. Introduction 
Blood cultures have became one of the most critically 
important and frequently performed tests in the clinical 
microbiology laboratory [1.2,3]. Fungemia and 
bacteremia are terms that simply represent the presence 
of fungi or bacteria in the patient blood[4]. Invasion of 
blood by microorganisms usually occurs by one of two 
mechanism, drainage from a primary focus  of infection 
via the lymphatic system to the vascular system, and 
direct entry of needles (intravenous drug users, or other 
contaminated intravascular devices, such as catheters or 
graft material[3,5]. Various culture systems may be 
used to recover microorganisms from these specimens, 
but for optimal recovery, a fully automated system and 
media that are directly inoculated with the specimens 
are most desirable [1,6]. Several systems are available 
for the detection of bacterimia and fungemia, which 
perform relatively well for the recovery of pathogenic  
isolates [7,8,9] . 
      
      One of such systems is the BACTEC system, which 
uses non invasive fluorescent technology to detect 
increases in Co2 produced by the microbial growth. The 
performance of such a system is influenced by several 
factors including the volume of blood samples, the use 
of resins shaking to increase the recovery of aerobic 
microorganisms, duration of incubation, and final 
subculture [10]. 
 
       The purpose of this study was to evaluate the 
efficacy of different techniques used for the detection of 
fungemia and bacteremia namely the conventional 
method and the fluorescent BACTEC technique. Also, 
to study and evaluate the harmful effect of fungal 
secondary metabolites on the internal organs using the 
experimental animal model. 
 
2. Materials & Methods  
This study was performed at El-Kasr El-Eni Hospital 
and the National Cancer Institute. 
2.1.Patient selection  
Five Hundred patients with a higher probability of 
bacteremia and or fungemia were subjected in this 
study. These patients were suffering from repeated 
episodes of fever accompanying one of the following 
diseases, rhematic heart diseases (145), Cancer (45), 
serious burns (22), hepatosplenomegally (54), chronic 
renal failure (39), post operative, surgery (31), car 
accidents (2), neonatal sepsis (59) and the rest of cases 
diagnosed as fever of unknown etiology. 
2.2. Sampling  
skin was disinfected with 70% ethanol followed by 2% 
povidine iodide for 2 minutes, then 20ml of blood were 
withdrawn from each patient via vein puncture using a 
sterile syringe, in case of neonates only 1-2ml of blood 
were withdrawn. Each blood sample was equally 
distributed among the study bottles (conventional broth 
culture bottle, BACTEC blood culture for aerobes, 
anaerobes and fungi), to achieve both equal volumes of 
blood and equal blood-broth ratio. 
2.3. Processing 
Conventional broth bottles inoculated with patients 
blood were incubated at 370C for fungal, aerobic and 
anaerobic bacterial growth. The bottle were visually 
examined in the first 18-24 hours and these showing 
evidence of microbial growth, such as hemolysis, 
turbidity, gas bubbles or the presence of discrete 
colonies on the surface of the sediment red cell layer 
were examined by direct microscopic smears and sub-
cultured on Sabourauds dextrose agar (SDA),  brain 
heart infusion blood agar and 5% sheep blood agar, 
Mackonky agar and chocholate agar. For those without 
macroscopic evidence of growth blind subcultures were 
done, if the subculture was negative, it was repeated 
after 24 hours then, daily from day 3 to 7, and if still 
negative a terminal subculture and smear stain  
examination was done at the end of the 14th day. 
        
     For the automatic BACTEC  (9120)  (Becton 
Dickinson) system: all inoculated vials were entered 
into the instrument. They were automatically tested 
every 10 minutes (positive vials were determined and 
appeared on the computer screen). The positive bottles 
were subcultured and Gram smear were prepared, at the 
end of the testing period, terminal subculture was 
performed for the negative bottles. [11]. 
2.4. Identification of the isolates  
      Yeast isolates were purified and  identified using the 
conventional morphological and biochemical tests 
[12,13]. Bacterial isolates were purified and identified 
following the laboratory procedures after Baily and 
Scott [14]. 
2.5.Additional investigations   
Indirect immune- fluorescence assay (IFA) following 
the method of Peter and Dawkins [15]. Screening of the 
yeast 2ry metabolites toxicity using the brine shrimp 
bioassay method of Bennett [16] .Testing the 
histopathological effect of yeast 2ry metabolites. 
        
     The isolated yeasts were grown on SDA plates for 
24 hours, then spore suspension was made by 
transferring yeast inoculums to sterilized test tube with 
phosphate buffered saline and the entration was 
adjusted for all yeasts to 103/ml. One ml of each tube 
was inoculated into 250ml sterilized conical flask 
containing 100ml  Sabouraud dextrose broth, incubated 
at 370C for one week then each flask was centrifuged at 
5000 rpm for 5 minutes, filtered using bacterial filters 
under aseptic conditions. The sterilized filtrate was kept 
for pathogenicity (toxicity) studies in experimental 
mice.  
  Male albino mice weighing 28-30gm each 
(obtained from animal housing division, National 
research center, Cairo, Egypt) was kept in cages in 5 
groups, each of 7 mice, with continuous supply of food 
and water. Mice of the first 4 groups were intravenously 
injected with 0.2ml of the yeast 2ry metabolites 
(infliltrate) of the isolated yeasts Candida albicans, C.  
glabrata,  C. tropicalis and Trichosporon beigelii, 
respectively. While the fifth group was intravenously 
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injected with 0.2ml of sterilized uninfected S.D broth as 
a control group. Mice were continuously observed over 
period of 8 weeks for the development of any clinical 
symptoms appearing as a result of infiltrate inoculation. 
As soon as clinical symptoms appeared, it was recorded 
and the mouse was sacrificed while the remainders were 
sacrificed at the termination of the experiment (8 
weeks). 
 
2.6. Histopathological work 
Liver kidney and spleen of all sacrificed mice were 
pathologically examined after dissection, fixed in 10% 
formal saline and processed in a routine manner for 
histopathological examination using H&E stain [17,18]. 
 
2.7. Statistical analysis 
 Statistical analysis was performed between yield of  
BACTEC and conventional systems, and their speed of 
detection using T-test for 2 samples assuming equal 
variances using the Microsoft excel spread sheet office 
1997. 
 
3. Results  
A total of 283 patients out of 500 studied cases (65.6%) 
showed a confirmed blood stream microbial infection 
(Septicemia). The classification of those patients 
according to medical diagnosis and type of blood 
stream microbial infection are shown in Table (1). The 
BACTEC system gave a significant higher yield and 
faster speed of detection than the conventional method, 
as 143 samples were detected by the BACTEC only, 48 
by the conventional only and 92 samples were detected 
by both systems (Table 2). Of those 207 (41.4%) for 
bacteria and 76 (15.21%) for yeasts (Table 2). (Table 3) 
demonstrates that Staphylococcus aureus is the 
predominant bacterium 52 cases (25.1%).  (Table 3) 
shows that Candida albicans is the predominant yeast 
60 (78.9%).  (Tables 4 and 5) showed the total yield of 
bacteria and yeasts with various diagnosed diseases and 
the recovery of bacterial and yeast isolates by the two 
systems used for the isolation. 
      Confirmation of the yeast positive cases was carried 
out using the indirect immune-florescence assay for the 
detection of antibodies in patients’ sera. All the isolated 
yeast pathogens gave positive result with this technique. 
 
 
 
 Table 1 . Classification of patients according to medical diagnosis and type of microbial infection. 
Type of diagnosis No. of 
patient 
No. of 
bacterial 
infection 
% No. of 
fungal 
infection 
% No. of 
negative 
growth 
% 
R.H.D 145 70 48.3% 5 3.4% 70 48.3 
F.U.O 62 17 27.4% 12 19.4% 33 53.2 
N.N 59 30 50.8% 12 20.3% 17 28.8 
Hepatosplenomegaly 54 25 46.3% 7 13.0% 22 70.7 
Cancer Patients 45 11 24.4% 29 64.4% 5 11.1 
Fungemia/Bacteremia 41 20 48.8% 2 4.9% 19 46.3 
C.R.F 39 17 43.6% 2 5.1% 20 51.3 
Post operative 31 9 29.0% 3 9.7% 19 61.3 
Burnet Patients 22 8 36.4% 2 9.1% 12 54.5 
Car accident 2 0 0.0 2 100.0% 0 00.0 
Total 500 207 41.40% 76 15.20% 217 43.4 
R.H.D: Rheumatic  heart disease ; F.U.O: Fever for unknown origin ; N.N: Neonates ; C.R.F: Chronic renal failure. 
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Table 2. Bacterial and Yeast fungal isolates recovered from blood samples of the patients using different system. 
Type of diagnoses Total BACTEC Broth 
R.H.D 145 5 70 3 37 40 1 9 10 1 24 
F.U.O 62 12 17 7 12 19 0 2 2 5 3 
N.N 59 12 30 5 7 12 3 7 10 4 16 
Hepatosplenomegaly 54 7 25 3 14 17 0 5 5 4 6 
Cancer Patients 45 29 11 15 5 20 6 2 8 8 4 
Fungemia/Bacteremia 41 2 20 2 8 10 0 6 6 0 6 
C.R.F 39 2 17 2 8 10 0 3 3 0 6 
Post operative 31 3 9 3 3 6 0 3 3 0 3 
Burnet Patients 22 2 8 2 5 7 0 2 2 0 1 
Car accident 2 2 0 2 0 2 0 0 0 0 0 
Total 500 76 207 44 99 143 10 39 49 22 69 
R.H.D: Rheumatic  heart disease ; F.U.O: Fever for unknown origin ; N.N: Neonates ; C.R.F: Chronic renal failure.  
 
 
 
 
Table 3. Bacteria and Yeast fungi recovered from blood specimens. 
Organism No. of isolates % 
a)Bacterial isolates 207 41.4
Staphylococcus aureus 52 25.1
Pseudomonas spp. 41 19.8
Klebsiella spp. 33 15.9
Escherichia coli 28 13.5
Proteus spp. 13 6.3 
Enterobacter spp. 8 3.9 
Streptococcus viridans 7 3.4 
Brucella spp. 6 2.9 
Citrobacter spp. 6 2.9 
Non haemolytic streptococci 5 2.4 
Acinetobacter spp. 4 1.9 
Salmonella spp. 2 1.0 
Serratia spp. 
 
2 1.0 
b)Fungal isolates 76 15.2
Candida albicans 60 78.9
Candida tropicalis 7 9.2 
Candida glabrata 5 6.6 
Trichosporon beigelii 4 5.3 
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   Table 4. Total yield of yeast and bacteria recovered form blood samples of patients with various diagnosed underlying disease. 
Type of diagnoses 
T
o
t
a
l
 
f
u
n
g
i
 
C
.
a
l
b
i
c
a
n
s
 
C
.
t
r
o
p
i
c
a
l
i
s
 
C
.
g
l
a
b
r
a
t
a
 
T
.
b
e
i
g
i
l
i
i
 
T
o
t
a
l
 
b
a
c
t
e
r
i
a
 
S
t
a
p
h
y
l
o
c
o
c
c
u
s
 
a
u
r
e
u
s
 
N
o
n
 
h
.
s
t
r
e
p
t
o
c
o
c
c
t
 
S
t
r
e
p
t
o
c
o
c
c
u
s
 
v
i
r
i
d
a
n
s
 
P
s
e
u
d
o
m
o
n
a
s
 
s
p
p
.
 
K
l
e
b
s
i
e
l
l
a
 
s
p
p
.
 
E
s
c
h
e
r
i
c
h
i
a
 
c
o
l
i
 
P
r
o
t
e
u
s
 
s
p
p
.
 
E
n
t
e
r
o
b
a
c
t
e
r
 
s
p
p
.
 
B
r
u
c
e
l
l
a
 
s
p
p
.
 
C
i
t
r
o
b
a
c
t
e
r
 
s
p
p
.
 
A
c
i
n
e
t
o
b
a
c
t
e
r
 
s
p
p
.
 
S
a
l
m
o
n
e
l
l
a
 
s
p
p
.
 
S
e
r
r
a
t
i
a
 
s
p
p
.
 
Cancer Patients 29 21 2 5 1 11 3 - 1 2 2 2 - 1 - - - - - 
Neonates 12 12 - - - 3 15 - 1 - 4 5 - 5 - - -  - 
Fever of unknown origin 12 8 3 - 1 17 2 1 - 2 3 2 2 - 2 1 1 - 1 
Hepatosplenomegaly 7 6 1 - - 25 7 - 2 5 5 3 2 - 1 - - - - 
Rheumatic heart disease 5 3 - - - 70 12 4 2 12 13 8 9 - 3 4 3 - - 
Post operative 3 5 - - - 9 4 - - 5 - - - - - - - - - 
Chronic renal failure 2 3 - - 1 17 3 - - 5 3 4 - 2 - - - - - 
Fungemia/Bacteremia 2 1 - - 1 20 4 - 1 8 3 2 - - - - - 2 - 
Car accident 2 1 1 - - - - - - - - - - - - - - - - 
Burnet Patients 2 12 - - - 8 2 - - 2 - 2 - - 1 1 - - 1 
Total 
% 
76 60 
78.9 
7 
9.2 
5 
6.6 
4 
5.3 
207 52 
25.1 
5 
2.4 
7 
3.4 
41 
19.8 
33 
15.9 
28 
13.5 
13 
6.3 
8 
3.9 
6 
2.9 
6 
2.9 
4 
1.9 
2 
1.0 
2 
1.0 
28Karam El-Din  et.al.                                                 JTUSCI 3: 23-32 (2010)                                                                                                                         
                            
 
Prevalence of microbial pathogens in blood cultures  
 
 
 Table 5. Total yield of yeast and bacteria isolated by the BACTEC and conventional system and their approximate speed 
of detection.  
 
 
3.1.Histopathological studies  
A screening mortality test of yeasts crude toxin using 
Brine shrimp toxicity test was carried out before 
applying the animal experimental studies. 
 
3.2. Mouse bioassay  
In vivo toxicity test of the yeast crude toxin, 
intraperitoneal injection of 1ml crude toxin of each of 
studied yeast proved to be severely lethal for the 
inoculated mice while the intraperitoneal mouse 
inoculation with 0.5ml crude toxin for each of the 
recovered yeasts separately showed a reduction in 
severity and longer survival times expressed in minutes 
post inoculation. The result of this toxicity test revealed 
the following descending tolerance pattern. Inoculation 
with 1ml caused death to all mice after few seconds 
with C.  
 
 
 
 
albicans, 1-2 min with C. glabrata, 2-3 min with C. 
tropicalis and 13-15 min with T. beigelii. While the 
inoculation with 0.5ml caused death to all mice  within 
3-4 min with C. albicans, 7-10 min with C.glabrata, 11-
17 min with C. tropicalis and 37-43 min with T. 
beigelii. The intraperitoneal inoculation with 1ml and 
0.5ml of sterilized medium not inoculated with any of 
the studied fungi (control) did not show any mortality 
for any of the injected mice.  
       Inoculation of groups of experimental mice with 
0.2ml of the double diluted crude toxin (intravenously) 
showed, a variety of clinical symptoms ranging from 
slight reduction in activity to severe convulsions with 
accelerated respiration rate ending with paralysis and 
death in different injected groups of mice according to 
the yeast species studied (Table 6). 
 
 
 
 
 
 
 
 
Yeast 
Tot. Bact & 
conv 
Bac. 
Only 
Conv. 
Only P. 
Speed (hours) 
P. 
Bactec Conv. 
C.albicans 
C.tropicallis 
C.glabrata 
T.beigelii 
Total yeast number 
(%) 
60 
7 
5 
4 
76 
26.9 
20 
- 
1 
1 
22 
7.8 
32 
6 
3 
3 
44 
15.6 
8 
1 
1 
- 
10 
3.5 
D
r=
32
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(p
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Gram + ve bacteria 
S. aureus 
Non.H.streptococci 
Steptococcus sp. 
 
52 
5 
7 
 
21 
3 
12 
 
18 
1 
2 
 
13 
1 
3 
 
21.3 
27.7 
25.3 
 
47.1 
51.3 
49.1 
Gram-ve bacteria 
Pseudomans sp. 
Klebsiella sp. 
Escherichia coli. 
Proteus sp. 
Enterobacter sp. 
Brucella sp. 
Citrobacter sp. 
Acinetobacter sp. 
Salmonella sp. 
Serratia sp. 
 
40 
33 
29 
13 
8 
6 
6 
4 
2 
2 
 
14 
11 
8 
5 
3 
- 
1 
2 
- 
- 
 
19 
18 
15 
8 
3 
6 
3 
2 
2 
2 
 
7 
4 
6 
- 
2 
- 
2 
- 
- 
- 
 
17.1 
18.3 
19.7 
16.3 
29.7 
91.7 
19.3 
23.1 
21.9 
17.1 
 
38.7 
51.3 
43.1 
51.9 
43.2 
- 
41 
49 
- 
- 
Total bacteria 
(%) 
207 
73 
70 
24.5 
99 
55 
38 
14.5 
   
Total 283 92 143 48     
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 Table 6. Percentage of mortalities and survival times of all mice  intravenously injected with 0.2ml of  diluted crude     
toxins of the studied yeast fungi .                                                        
Candida spp. Day of 
death  
No of 
dead 
mice 
Survivors % of mortalities 
Number of Survivors 
till end of the experiment 
(8 weeks) 
Candida albicans 3rd 1 6 14.3% 
0 6
th 1 5 28.6% 
8th 1 4 42.9% 
9th 2 2 71.4 
Candida tropicalis 3rd 1 6 14.3% 
2 
5th 1 5 28.6% 
11th 1 4 42.9% 
19th 2 2 71.4% 
Candida glabrata 4th 1 6 14.3% 
3 7
th 1 5 28.6% 
11th 1 4 42.9% 
13th 1 3 57.1% 
Trichosporon beigelii 11th 1 6 14.3% 
4 
18th 1 15 28.6% 
27th  4 42.9% 
11th 1 6 14.3% 
*All control mice survived till the end of the experiment without mortalities or any abnormal clinical  symptoms
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        A varied percentage of mortalities and 
survival times were observed in all mice injected 
with 0.2 of the diluted crude toxin with the 
highest mortality rate in case of Candida 
albicans crude toxin and the least mortalities and 
longer survival times was observed in case of 
Trichosporon beigelii crude toxin injection 
(Table 6) . While the control animals inoculated 
with 0.2ml of sterilized, non inoculated and 
diluted medium showed no mortalities or clinical 
symptoms. Various histopathological changes 
have been noticed in the livers , kidneys and 
spleens of all injected mice with 0.2ml of the 
double diluted crude toxins or 2ry metabolites of 
the yeasts recovered from patient blood stream  
are shown in Fig. 1 ( A , B , C , D , E , and F ). 
 
3.3. Statistical analysis 
Correlation analyses revealed non-significant 
differences considering the microbiological data 
and a considerable significance considering 
clinical data. The correlation between positive 
cases and sex was significant (where number of 
males exceeded that of the females in both 
bacterial and fungal infections). The correlation 
between bacterial and fungal infections towards 
the different clinical cases (rheumatic heart 
fever, neonate, hepatomegaly, cancer,  
bacteremia,  fungemia and chronic renal failure) 
was highly significant While the correlation with 
other clinical cases (post operative, burning, car 
accident) was  significant, but the correlation 
with the clinical cases (fever of unknown origin) 
was non-significant with bacterial infections and 
highly significant with fungal infection. The 
correlation between the total tested cases and the 
total positive cases was significant. The 
correlation between the tested organisms and the 
mortality rate in brine shrimp bioassay was 
significant 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1. (A)Liver with minimal damage inflammatory     
infiltration, (B) Liver with necrotic area and   
consolidation of blood vessels, (C) Kidney showing 
necrosis and vaculation, (D) Kidney showing necrotic 
glomerulii and renal tubules, (E) Spleen with severely 
necrotic area and (F) spleen showing  necrosis and 
fibrosis around an artery. 
4. Discussion 
The presence of living microorganisms in the 
patient blood represents one of the most 
important squealae of infection which constitute 
a considerable problem as the estimated number 
of patients with fungemia or bacteremia 
exceeding millions and are annually increasing 
with associated mortality ranging from 20 to 
50% every year [4, 19]. 
      Yeast infection namely candidiasis is an 
increasingly common problem in hospitalized 
patients, with epidemiologic surveys revealing 
that Candida spp. Are now the fourth most 
common pathogens isolated from the blood of 
hospitalized patients [7]. 
      The premature infants are at high increasing 
risk of blood stream infection which may extend 
to adults suffering from hematological and non 
hematological malignancy. Diabetes mellitus, 
renal failure requiring dialysis, hepatocirrhosis, 
immune deficiency syndrome and loss of skin 
barrier as in serious burns, skin ulcers and 
surgery of all types. Also the long term  uptake 
of  certain.  Medications such as corticosteroids, 
cytotoxic drugs used for chemotherapy of cancer 
patients, alter the immune functioning of the 
blood and increase the risk of blood stream 
microbial Infection [ 20]. 
        In the present study the BACTEC (9120) 
blood culture system was superior to the 
conventional system regarding the number of 
isolates detected by each system (143 for 
BACTEC,49 for broth and 91 for both ) and the 
time of recovery of organisms. This was 
attributed to the effect of continuous agitation in 
BACTEC system that proved to increase the 
yield and speed of detection as reported by other 
investigators [21,22]. Although the BACTEC 
system was superior to the conventional in both 
yield and speed of detection, it has a major defect 
which should be considered. The presence of 
false positive radiometric reading  which result 
in an overall load of work and increased time 
spent for the confirmation of such false positive 
cultures. While the main disadvantage of the 
conventional method is the great number of the 
false positive cultures compared with the 
BACTEC system. In addition, the delay for 18-
24 hours or longer and the need for repeated 
blind subcultures and microscopic stains. Even 
after such delay, culture may fail to yield growth. 
These finding were also concluded by workers 
[4,5]. 
       Out of the 207 cases with bacterial growth 
52 (25.1%) were due to Staphylococcus aureus,  
while 60 (78.9%) cases were due to Candida 
albicans out of the 76 cases with fungal growth. 
These results were in agreement with those of 
Silva et al.[23]  who found that Candida  
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albicans represented 48.1% and other Candida 
spp. were of lower occurrence. He also reported 
that Cryptococcus neofermans was recovered in 
10 of invasive fungal infection (blood) besides 
Saccharomyces cervisiae and Trichosporon 
mucoides as two emerging pathogens were also 
isolated. 
       Numerous bacterimia and candidemia 
studies have documented the increasing 
importance of invasive microbial infection of 
blood stream of various groups of patients 
parallel to those included in the present study 
(renal failer [24] premature neonates [25,26] in 
immunocompromised patients [27] ; in bone 
marrow transplantation [28] and in  cancer 
patients [29]. 
       A critical epidemiological study was 
conducted in Spain (2002-2003) as a population 
– based surveillance for Candida blood stream 
infections to determine its incidence, the extent 
of anti fungal resistance, and risk factors for 
mortality. They defined early mortality as 
occurring between days 3 to 7 after candidemia 
and late mortality as occurring between days 8 to 
30. They detected 345 of candidemia, for an 
average annual incidence of 4.3 cases/100.000 
population. Overall mortality was 44% . Candida 
albicans was the most frequent species (51% of 
cases) followed by C. parapsilosis (23%), C. 
tropicalis (10%), C. glabrate (8%), C. Krusei 
(4%) and other species (3%) [30]. Also a long-
term nation wide prospective candidemia study 
was conducted in Norway (1992-2003). They 
reported that, the average annual incidence 
varied markedly between age groups. The 
incidence was high in patients aged <1 year and 
in patients age > 70 years. Four Candida species 
C. albicans (70%), C. globrata (13%). C. 
tropicalis (7%), and C. parapsilosis (6%) 
accounted for 95.5 of the isolates. The species 
distribution has been constant during the 13-year 
study period. All C. albicans strains were 
susceptible to fluconzaole. [31]. 
       Fungal (yeast) secondary metabolites might 
have various toxicological health impacts, 
however, evaluation of their health effects 
caused by a great variety of these organic 
compounds, remained difficult since information 
about their toxicological impact is lacking [32]. 
A number of Candida albicans antigens can 
reach the blood stream subject with invasive 
candidiasis. The molecules investigated include a 
thermostable protein antigen, believed to be a 
glycoprotein and  a series of  metabilites. 
Candida antigens are difficult to study for 
several reasons, they often form 
immunocomplexes and may appear in circulation 
only briefly when the lesion is localized. Mannan 
has been detected in 47 to 100% of patients with 
invasive candidiasis depending on the technique 
used, this antigen is not detected in healthy 
humans or in patients only colonized or having a 
superficial infection with Candida. The mannan 
antigen can reach concentration of 1-10 mg/ml in 
the blood stream [33]. The D-arabitol (five 
carbon sugar alcohol) which is a metabolite of 
most pathogenic Candida species in vitro as well 
as in vivo. The endogenous D-arabitol are 
present in human body fluids such as serum and 
urine accompanying Candida pathogensis [34]. 
        In the present investigation the pathogenic 
role of such variety of compounds, collectively 
included in the yeast culture filtrate, (especially 
those of C.albicans, C. glabrata and C. 
tropicallis) was confirmed with an obvious 
effects on the viability, and induction appearance 
of various clinical symptoms ending with 
mortalities accompanied with destructive 
changes in the livers, kidney and spleen of the 
intravenously injected mice. The reports dealing 
with the pathogenic role of yeasts 2ry metabolites 
are scanty, however our findings support these 
reports [35,36]. 
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